We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

AusPAR: Casirivimab/imdevimab

Australian Public Assessment Report

AusPAR

AusPAR: Casirivimab/imdevimab [PDF, 2.49 MB]

AusPAR: Casirivimab/imdevimab [DOCX, 15.34 MB]

Attachment: Product Information for Casirivimab/imdevimab [PDF, 597.17 KB]

Attachment: Product Information for Casirivimab/imdevimab [DOCX, 453.25 KB]

Device/Product Name

Ronapreve

Active ingredients

Casirivimab/imdevimab

AusPAR Date

25 October 2021

Published

2 November 2021

Submission Number

PM-2021-03952-1-2

Submission Type

New biological entity

Decision

Approved for provisional registration

Product types

Prescription medicines